Article Details

Syndax Pharmaceuticals (NASDAQ:SNDX) Cut to “Sell” at ValuEngine

Retrieved on: 2019-02-27 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

Syndax Pharmaceuticals (NASDAQ:SNDX) Cut to “Sell” at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc boosted its holdings in shares of Syndax Pharmaceuticals by 75.5% in the 3rd quarter. <b>Sofinnova Ventures</b> Inc now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo